Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 23


Extraordinary cause of acute gastric dilatation and hepatic portal venous gas: Chronic use of synthetic cannabinoid.

Sevinc MM, Kinaci E, Bayrak S, Yardimci AH, Cakar E, Bektaş H.

World J Gastroenterol. 2015 Oct 7;21(37):10704-8. doi: 10.3748/wjg.v21.i37.10704.


Endocannabinoid 2-Arachidonoylglycerol Self-Administration by Sprague-Dawley Rats and Stimulation of in vivo Dopamine Transmission in the Nucleus Accumbens Shell.

De Luca MA, Valentini V, Bimpisidis Z, Cacciapaglia F, Caboni P, Di Chiara G.

Front Psychiatry. 2014 Oct 17;5:140. doi: 10.3389/fpsyt.2014.00140. eCollection 2014.


Endocannabinoids anandamide and 2-arachidonoylglycerol are substrates for human CYP2J2 epoxygenase.

McDougle DR, Kambalyal A, Meling DD, Das A.

J Pharmacol Exp Ther. 2014 Dec;351(3):616-27. doi: 10.1124/jpet.114.216598. Epub 2014 Oct 2.


Tapping into the endocannabinoid system to ameliorate acute inflammatory flares and associated pain in mouse knee joints.

Krustev E, Reid A, McDougall JJ.

Arthritis Res Ther. 2014 Sep 27;16(5):437. doi: 10.1186/s13075-014-0437-9.


Patterns and correlates of cannabis use among individuals with HIV/AIDS in Maritime Canada.

Harris GE, Dupuis L, Mugford GJ, Johnston L, Haase D, Page G, Haldane H, Harris N, Midodzi WK, Dow G.

Can J Infect Dis Med Microbiol. 2014 Spring;25(1):e1-7.


The endocannabinoid system and sex steroid hormone-dependent cancers.

Ayakannu T, Taylor AH, Marczylo TH, Willets JM, Konje JC.

Int J Endocrinol. 2013;2013:259676. doi: 10.1155/2013/259676. Epub 2013 Nov 27. Review.


Microarray and pathway analysis reveal distinct mechanisms underlying cannabinoid-mediated modulation of LPS-induced activation of BV-2 microglial cells.

Juknat A, Pietr M, Kozela E, Rimmerman N, Levy R, Gao F, Coppola G, Geschwind D, Vogel Z.

PLoS One. 2013 Apr 24;8(4):e61462. doi: 10.1371/journal.pone.0061462. Print 2013.


Chemical probes of endocannabinoid metabolism.

Blankman JL, Cravatt BF.

Pharmacol Rev. 2013 Mar 19;65(2):849-71. doi: 10.1124/pr.112.006387. Print 2013 Apr. Review.


Chemistry, metabolism, and toxicology of cannabis: clinical implications.

Sharma P, Murthy P, Bharath MM.

Iran J Psychiatry. 2012 Fall;7(4):149-56.


Unmet need for treatment for substance use disorders across race and ethnicity.

Mulvaney-Day N, DeAngelo D, Chen CN, Cook BL, Alegría M.

Drug Alcohol Depend. 2012 Sep;125 Suppl 1:S44-50. doi: 10.1016/j.drugalcdep.2012.05.005. Epub 2012 Jun 2.


Blurred boundaries: the therapeutics and politics of medical marijuana.

Bostwick JM.

Mayo Clin Proc. 2012 Feb;87(2):172-86. doi: 10.1016/j.mayocp.2011.10.003. Review.


Inhibition of monoacylglycerol lipase attenuates nonsteroidal anti-inflammatory drug-induced gastric hemorrhages in mice.

Kinsey SG, Nomura DK, O'Neal ST, Long JZ, Mahadevan A, Cravatt BF, Grider JR, Lichtman AH.

J Pharmacol Exp Ther. 2011 Sep;338(3):795-802. doi: 10.1124/jpet.110.175778. Epub 2011 Jun 9.


Differential transcriptional profiles mediated by exposure to the cannabinoids cannabidiol and Δ9-tetrahydrocannabinol in BV-2 microglial cells.

Juknat A, Pietr M, Kozela E, Rimmerman N, Levy R, Coppola G, Geschwind D, Vogel Z.

Br J Pharmacol. 2012 Apr;165(8):2512-28. doi: 10.1111/j.1476-5381.2011.01461.x.


Inhibition of endocannabinoid catabolic enzymes elicits anxiolytic-like effects in the marble burying assay.

Kinsey SG, O'Neal ST, Long JZ, Cravatt BF, Lichtman AH.

Pharmacol Biochem Behav. 2011 Mar;98(1):21-7. doi: 10.1016/j.pbb.2010.12.002. Epub 2010 Dec 8.


The CB2 cannabinoid receptor-selective agonist O-3223 reduces pain and inflammation without apparent cannabinoid behavioral effects.

Kinsey SG, Mahadevan A, Zhao B, Sun H, Naidu PS, Razdan RK, Selley DE, Imad Damaj M, Lichtman AH.

Neuropharmacology. 2011 Feb-Mar;60(2-3):244-51. doi: 10.1016/j.neuropharm.2010.09.004. Epub 2010 Sep 16.


Cannabinoid receptor CB1 mediates baseline and activity-induced survival of new neurons in adult hippocampal neurogenesis.

Wolf SA, Bick-Sander A, Fabel K, Leal-Galicia P, Tauber S, Ramirez-Rodriguez G, Müller A, Melnik A, Waltinger TP, Ullrich O, Kempermann G.

Cell Commun Signal. 2010 Jun 17;8:12. doi: 10.1186/1478-811X-8-12.


Fatty acid amide hydrolase and monoacylglycerol lipase inhibitors produce anti-allodynic effects in mice through distinct cannabinoid receptor mechanisms.

Kinsey SG, Long JZ, Cravatt BF, Lichtman AH.

J Pain. 2010 Dec;11(12):1420-8. doi: 10.1016/j.jpain.2010.04.001. Epub 2010 Jun 16.


The multiple functions of the endocannabinoid system: a focus on the regulation of food intake.

Tibiriça E.

Diabetol Metab Syndr. 2010 Jan 21;2:5. doi: 10.1186/1758-5996-2-5.


The analgesic potential of cannabinoids.

Elikkottil J, Gupta P, Gupta K.

J Opioid Manag. 2009 Nov-Dec;5(6):341-57. Review. Erratum in: J Opioid Manag. 2010 Jan-Feb;6(1):14. Elikottil, Jaseena [corrected to Elikkottil, Jaseena].


Inhibition of human tumour prostate PC-3 cell growth by cannabinoids R(+)-Methanandamide and JWH-015: involvement of CB2.

Olea-Herrero N, Vara D, Malagarie-Cazenave S, Díaz-Laviada I.

Br J Cancer. 2009 Sep 15;101(6):940-50. doi: 10.1038/sj.bjc.6605248. Epub 2009 Aug 18.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk